decisionhealth Newsletters, Part B News - 2008 Issue 1 (January)
Despite delay, anti-markup rule could affect you right now
Subscribe or sign in to view the full article.
Article Overview
This article discusses CMS’s delayed anti-markup rule and why its impact may extend beyond the specific lab arrangements that originally drew attention. It is aimed at physician practices, laboratory professionals, and compliance-focused readers who need a general understanding of the policy’s scope, the types of specialties most likely to be affected, and the broader relationship to in-office pathology services and physician-office billing. The discussion also touches on concerns about future limits under the Stark in-office ancillary exception.
Why This Topic Matters
The article helps readers assess whether a delayed CMS policy could still affect current billing and service arrangements in physician offices. It is relevant for compliance planning, laboratory contracting, and understanding how office-based pathology services may be scrutinized.
What You Will Learn
- What the CMS anti-markup policy is broadly about
- Which practice settings and specialties may be most likely to notice the policy’s effects
- How the article frames the relationship between in-office pathology services and outside laboratory arrangements
- Why the policy is discussed alongside broader concerns about physician office ancillary services
Who Should Read This
- Physician practice administrators
- Compliance staff
- Pathology and laboratory professionals
- Medical billing and coding professionals
- Healthcare attorneys and consultants
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com